614750-85-5

Usage

Uses

Used in Organic Synthesis:
Phosphonic acid, P-[(6-Methyl-2-pyridinyl)(phenylamino)methyl]-, diphenyl ester is used as a catalyst or reagent in various organic synthesis processes, contributing to the formation of complex organic molecules and facilitating specific chemical reactions.
Used in Pharmaceutical Applications:
In the pharmaceutical industry, Phosphonic acid, P-[(6-Methyl-2-pyridinyl)(phenylaMino)Methyl]-, diphenyl ester serves as an intermediate for the synthesis of various drugs, playing a crucial role in the development of new medications and therapies.
Used in Material Development:
Phosphonic acid, P-[(6-Methyl-2-pyridinyl)(phenylamino)methyl]-, diphenyl ester is utilized in the development of new materials, such as polymers and nanomaterials, due to its unique chemical properties that can enhance the performance and functionality of these materials.
Used in Antimicrobial Applications:
Phosphonic acid, P-[(6-Methyl-2-pyridinyl)(phenylaMino)Methyl]-, diphenyl ester has been studied for its potential antimicrobial properties, making it a candidate for use in applications that require the inhibition of microbial growth, such as in medical devices or as an additive in various products.
Used in Antiviral Applications:
Phosphonic acid, P-[(6-Methyl-2-pyridinyl)(phenylamino)methyl]-, diphenyl ester has also been investigated for its potential antiviral properties, suggesting its use in the development of antiviral agents or treatments.

Upstream product

• 1122-72-1 6-methyl-2-pyridinecarboxaldehyde 
• 4712-55-4 diphenyl hydrogen phosphite 
• 41839-47-8 diphenoxyphosphine 
• 62-53-3 aniline 

Downstream Products

• 813449-09-1 2-[3-hydroxy-4-nitrophenyl]-1-[6-methylpyridin-2-yl]-ethanone 
• 1338072-70-0 C₂₃H₁₉N₇OS 
• 1338072-68-6 C₂₃H₁₆F₃N₇S 
• 1338072-65-3 C₂₃H₁₉N₇S 
• 1338072-64-2 C₂₂H₁₆ClN₇S 
• 1338072-63-1 C₂₂H₁₆FN₇S 
• 746667-09-4 6-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridine 
• 1338072-42-6 C₂₄H₂₀N₈OS 
• 1338072-41-5 C₂₄H₁₈N₈S 
• 1338072-40-4 C₂₃H₁₉N₇S 
• 1338072-43-7 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-N-(1-benzylpiperidin-4-yl)-3-(6-methylpyridin-2-yl)-1H-pyrazole-1-carbothioamide 
• 1338073-05-4 C₂₂H₁₅Cl₂N₇S 
• 1338073-03-2 C₂₂H₁₅Cl₂N₇S 
• 1338073-02-1 C₂₂H₁₅F₂N₇S 

Relevant academic research and scientific papers

SUBSTITUTED 1,5-NAPHTHYRIDINES OR QUINOLINES AS ALK5 INHIBITORS

The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.

FUSED RING HETEROARYL COMPOUNDS AS ALK4/5 INHIBITORS

The invention provides novel substituted heterocyclic compounds represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of ALK5 and/or ALK4 and are useful in the treatment of pulmonary fibrosis, NASH, obesity, diabetes, cancers and other inflammation.

4- (HETEROCYCLYL- FUSED PHENYL)- 3- (PHENYL OR PYRID -2- YL) PYRAZOLES AS INHIBITORS OF THE ALK-5- RECEPTOR

The invention relates to novel pyrazole derivatives which are inhibitors of the transforming growth factor, ("TGF")-β signalling pathway, in particular, the phosphorylation of smad2 or smad3 by the TGF-β type I or activin-like kinase ("ALK")-5 receptor, m